Wells Fargo’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,307
| Closed | -$130K | – | 7464 |
|
|
2025
Q1 | $130K | Buy |
22,307
+712
| +3% | +$3.75K | ﹤0.01% | 4958 |
|
|
2024
Q4 | $80.3K | Buy |
21,595
+4,971
| +30% | +$22.9K | ﹤0.01% | 5317 |
|
|
2024
Q3 | $92.9K | Buy |
16,624
+92
| +0.6% | +$644 | ﹤0.01% | 5064 |
|
|
2024
Q2 | $139K | Buy |
16,532
+3,880
| +31% | +$41.4K | ﹤0.01% | 4744 |
|
|
2024
Q1 | $183K | Buy |
12,652
+1,363
| +12% | +$22.5K | ﹤0.01% | 4527 |
|
|
2023
Q4 | $243K | Buy |
11,289
+2,115
| +23% | +$37.7K | ﹤0.01% | 4346 |
|
|
2023
Q3 | $176K | Sell |
9,174
-5,709
| -38% | -$122K | ﹤0.01% | 4445 |
|
|
2023
Q2 | $378K | Buy |
14,883
+4,779
| +47% | +$138K | ﹤0.01% | 4146 |
|
|
2023
Q1 | $365K | Buy |
10,104
+8,678
| +609% | +$305K | ﹤0.01% | 4050 |
|
|
2022
Q4 | $56.5K | Sell |
1,426
-3,265
| -70% | -$136K | ﹤0.01% | 4804 |
|
|
2022
Q3 | $220K | Sell |
4,691
-1,164
| -20% | -$54K | ﹤0.01% | 4193 |
|
|
2022
Q2 | $257K | Sell |
5,855
-6,623
| -53% | -$364K | ﹤0.01% | 4155 |
|
|
2022
Q1 | $902K | Sell |
12,478
-11,971
| -49% | -$863K | ﹤0.01% | 3985 |
|
|
2021
Q4 | $1.98M | Sell |
24,449
-4,259
| -15% | -$427K | ﹤0.01% | 3518 |
|
|
2021
Q3 | $3.34M | Sell |
28,708
-7,437
| -21% | -$973K | ﹤0.01% | 3220 |
|
|
2021
Q2 | $5.99M | Sell |
36,145
-10,025
| -22% | -$1.56M | ﹤0.01% | 2702 |
|
|
2021
Q1 | $6.44M | Sell |
46,170
-12,297
| -21% | -$2.01M | ﹤0.01% | 2595 |
|
|
2020
Q4 | $10.1M | Buy |
58,467
+9,338
| +19% | +$1.51M | ﹤0.01% | 2080 |
|
|
2020
Q3 | $6.84M | Sell |
49,129
-18,486
| -27% | -$2.47M | ﹤0.01% | 2208 |
|
|
2020
Q2 | $8.08M | Sell |
67,615
-16,787
| -20% | -$1.99M | ﹤0.01% | 2027 |
|
|
2020
Q1 | $8.44M | Buy |
84,402
+15,657
| +23% | +$1.88M | ﹤0.01% | 1803 |
|
|
2019
Q4 | $8.08M | Buy |
68,745
+33,460
| +95% | +$3.31M | ﹤0.01% | 2147 |
|
|
2019
Q3 | $3.03M | Buy |
35,285
+4,508
| +15% | +$341K | ﹤0.01% | 2980 |
|
|
2019
Q2 | $2M | Sell |
30,777
-4,723
| -13% | -$294K | ﹤0.01% | 3366 |
|
|
2019
Q1 | $2.22M | Sell |
35,500
-64,970
| -65% | -$3.06M | ﹤0.01% | 3271 |
|
|
2018
Q4 | $3.91M | Sell |
100,470
-111,862
| -53% | -$4.97M | ﹤0.01% | 2681 |
|
|
2018
Q3 | $12.1M | Sell |
212,332
-1,154,648
| -84% | -$72.2M | ﹤0.01% | 1919 |
|
|
2018
Q2 | $109M | Buy |
1,366,980
+543,401
| +66% | +$45.1M | 0.03% | 543 |
|
|
2018
Q1 | $71.4M | Sell |
823,579
-45,510
| -5% | -$3.67M | 0.02% | 722 |
|
|
2017
Q4 | $60M | Sell |
869,089
-212,983
| -20% | -$17M | 0.02% | 789 |
|
|
2017
Q3 | $98.3M | Buy |
1,082,072
+108,289
| +11% | +$9.27M | 0.03% | 555 |
|
|
2017
Q2 | $72.5M | Buy |
973,783
+378,422
| +64% | +$30.3M | 0.02% | 685 |
|
|
2017
Q1 | $55.8M | Buy |
595,361
+50,490
| +9% | +$4.57M | 0.02% | 800 |
|
|
2016
Q4 | $39.6M | Buy |
544,871
+80,641
| +17% | +$6.9M | 0.01% | 949 |
|
|
2016
Q3 | $48.5M | Sell |
464,230
-1,070,877
| -70% | -$96.7M | 0.02% | 798 |
|
|
2016
Q2 | $113M | Buy |
1,535,107
+142,793
| +10% | +$9.69M | 0.04% | 440 |
|
|
2016
Q1 | $78.3M | Buy |
1,392,314
+809,726
| +139% | +$47.8M | 0.03% | 551 |
|
|
2015
Q4 | $39.3M | Buy |
582,588
+53,684
| +10% | +$2.87M | 0.02% | 891 |
|
|
2015
Q3 | $24.5M | Buy |
528,904
+121,299
| +30% | +$5.88M | 0.01% | 1163 |
|
|
2015
Q2 | $21.9M | Buy |
407,605
+403,758
| +10,495% | +$20.6M | 0.01% | 1320 |
|
|
2015
Q1 | $185K | Buy |
3,847
+559
| +17% | +$24.3K | ﹤0.01% | 4459 |
|
|
2014
Q4 | $128K | Buy |
+3,288
| New | +$104K | ﹤0.01% | 4645 |
|
Other funds holding NVRO
Wells Fargo's NVRO Position: Q2 2025 in Review
Wells Fargo sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 22,307 shares — an estimated $130K sold.
Wells Fargo first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $113M in Q2 2016. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Wells Fargo reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Wells Fargo sold 22,307 NEVRO CORP. shares in Q2 2025, an estimated $130K.
- Wells Fargo first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
- Wells Fargo's NEVRO CORP. position peaked at $113M in Q2 2016.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.